Vivani Medical (VANI) Current Deferred Revenue (2014 - 2021)
Vivani Medical (VANI) posted quarterly Current Deferred Revenue of $335000.0 for Q3 2021, little changed year-over-year from $335000.0 in Q3 2020, and little changed quarter-over-quarter from $335000.0 in Q2 2021.
Vivani Medical (VANI) Current Deferred Revenue (2014 - 2021) Analysis & Trends
Vivani Medical's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $335000.0 for Q3 2021.
- In Q3 2021, Current Deferred Revenue changed 0.0% year-over-year to $335000.0; the TTM figure through Sep 2021 stood at $335000.0 (changed 0.0% YoY), while the FY2020 annual figure was $335000.0, changed 0.0% from the prior year.
- Current Deferred Revenue for Q3 2021 stood at $335000.0, roughly flat from $335000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $557000.0 in Q2 2019, with the low at $48000.0 in Q4 2017.
- The 5-year median for Current Deferred Revenue is $335000.0 (2019), against an average of $306333.3.
- The sharpest annual moves came in 2017 and 2019: Current Deferred Revenue slumped 43.53% in 2017, then jumped 399.1% in 2019.
- Vivani Medical's Current Deferred Revenue stood at $48000.0 in 2017, then soared by 247.92% to $167000.0 in 2018, then jumped by 100.6% to $335000.0 in 2019, then changed by 0.0% to $335000.0 in 2020, then changed by 0.0% to $335000.0 in 2021.
- Business Quant data shows VANI's Current Deferred Revenue at $335000.0 in Q3 2021, $335000.0 in Q2 2021, and $335000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 335,000.00 |
| Jun 30, 2021 | 335,000.00 |
| Mar 31, 2021 | 335,000.00 |
| Dec 31, 2020 | 335,000.00 |
| Sep 30, 2020 | 335,000.00 |
| Jun 30, 2020 | 335,000.00 |
| Mar 31, 2020 | 335,000.00 |
| Dec 31, 2019 | 335,000.00 |
| Sep 30, 2019 | 554,000.00 |
| Jun 30, 2019 | 557,000.00 |
| Mar 31, 2019 | 218,000.00 |
| Dec 31, 2018 | 167,000.00 |
| Sep 30, 2018 | 111,000.00 |
| Jun 30, 2018 | 260,000.00 |
| Dec 31, 2017 | 48,000.00 |
| Dec 31, 2016 | 85,000.00 |
| Sep 30, 2015 | 783,453.00 |
| Dec 31, 2014 | 599,904.00 |